SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-253536
Filing Date
2023-10-10
Accepted
2023-10-10 17:00:26
Documents
3
Period of Report
2023-10-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A d495377dpre14a.htm PRE 14A 378661
2 GRAPHIC g495377g12m01.jpg GRAPHIC 369884
3 GRAPHIC g495377g12m02.jpg GRAPHIC 339710
  Complete submission text file 0001193125-23-253536.txt   1357233
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41390 | Film No.: 231318632
SIC: 6770 Blank Checks